Charles River Laboratories

Healthcare · Diagnostics & Research

305.00$ -1.9% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Balance Sheet

Charles River Laboratories (CRL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 7,532 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CRL
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	2,690	2,712	2,697	2,774	2,866	2,930	3,001	3,866	3,797	3,856	3,927	4,625	4,583	4,693	5,202	5,241	5,213	5,491	5,809	6,720	7,058	7,024	7,075	7,529	7,383	7,603	7,699	7,772	7,607	8,195	8,153	7,948	8,004	7,528	7,582	7,561	7,514	7,135	7,730	7,532
Current Assets	655	657	700	738	782	827	843	890	838	898	866	1,010	972	1,021	1,208	1,235	1,140	1,201	1,423	1,268	1,379	1,274	1,333	1,393	1,415	1,439	1,448	1,505	1,444	1,609	1,668	1,499	1,495	1,403	1,506	1,470	1,532	1,447	1,489	1,529
Cash	106	118	132	116	124	164	188	192	139	195	126	201	165	238	372	402	243	228	465	223	213	245	242	206	194	234	202	200	157	277	327	179	210	195	229	183	208	214	192	192
Cash & Short-Term Investments	113	118	135	140	154	164	190	193	144	195	127	201	166	239	373	403	244	229	466	224	214	246	243	207	195	234	202	200	157	277	327	179	210	195	229	183	208	214	192	192
Receivables	360	364	384	399	422	430	440	479	487	472	496	545	524	514	542	533	572	618	611	644	660	650	707	755	778	752	788	801	799	780	787	762	754	721	757	768	734	709	700	712
Inventory	99	96	98	105	107	115	119	124	126	128	130	135	156	161	163	168	181	186	194	194	182	199	221	257	262	256	263	285	293	380	361	349	336	279	290	280	303	299	360	346
Property, Plant & Equipment	767	756	747	759	767	782	789	896	897	933	907	1,006	1,008	1,044	1,033	1,197	1,206	1,124	1,315	1,466	1,461	1,584	1,626	1,766	1,754	1,857	1,903	1,927	1,901	–	–	–	2,025	2,017	1,990	1,992	1,966	2,017	–	–
Goodwill	764	788	756	776	800	805	836	1,254	1,253	1,247	1,246	1,527	1,522	1,541	1,732	1,736	1,778	1,809	1,891	2,540	2,736	2,712	2,696	2,860	2,776	2,850	2,902	2,917	2,885	3,095	3,070	3,080	3,125	2,847	2,873	2,936	2,922	2,764	3,040	3,077
Intangible Assets	396	394	370	369	375	370	370	649	630	611	595	735	702	689	833	806	803	788	796	1,057	1,100	1,061	1,020	1,032	968	955	958	930	886	864	828	800	778	723	656	602	571	340	249	253
Total Liabilities	1,802	1,858	1,803	1,792	1,825	1,866	1,841	2,664	2,523	2,518	2,505	3,147	3,018	3,026	3,522	3,460	3,288	3,347	3,593	4,366	4,594	4,432	4,404	4,836	4,711	4,579	4,543	4,472	4,256	4,536	4,449	4,175	4,176	4,020	4,341	4,161	4,063	3,924	4,742	4,686
Current Liabilities	412	430	383	424	416	464	407	518	540	558	530	636	682	710	691	728	787	840	803	930	984	1,033	994	1,048	1,014	1,092	981	1,008	994	1,055	955	948	1,012	994	1,051	1,080	1,122	1,120	1,094	1,135
Short-Term Debt	26	27	27	27	27	31	3.1	31	32	35	50	53	54	59	70	78	73	75	29	35	34	36	40	51	47	50	4.0	412	422	441	2.6	3.2	43	0.0	0.0	0.0	2.6	61	–	–
Accounts Payable	66	68	61	65	66	78	73	67	78	66	79	99	107	111	103	83	97	122	127	111	128	198	226	211	182	206	120	140	136	169	130	133	136	140	149	146	170	149	134	141
Long-Term Debt	1,233	1,208	1,170	1,116	1,156	1,114	1,101	1,769	1,625	1,611	1,514	2,012	1,856	1,822	2,301	2,182	1,943	1,904	2,176	2,701	2,867	2,639	2,653	2,997	2,937	2,708	2,744	2,678	2,514	2,647	2,660	2,409	2,327	2,240	2,511	2,332	2,185	2,112	2,663	2,620
Shareholders' Equity	868	837	876	963	1,022	1,045	1,140	1,182	1,253	1,317	1,398	1,455	1,532	1,635	1,652	1,753	1,897	2,115	2,184	2,318	2,427	2,535	2,610	2,648	2,627	2,976	3,109	3,252	3,306	3,597	3,640	3,723	3,782	3,462	3,194	3,353	3,405	3,165	2,941	2,840
Retained Earnings	121	165	212	266	319	289	346	400	460	42	97	141	214	280	331	399	501	625	687	775	879	981	1,074	1,183	1,280	1,433	1,536	1,633	1,720	1,887	1,960	2,054	2,123	1,812	1,838	1,890	1,944	1,389	1,374	1,372
Shares Outstanding	48	48	48	48	48	47	49	49	49	49	49	50	50	50	50	50	51	51	51	51	52	52	51	51	51	51	51	51	52	52	52	52	52	51	51	49	49	49	49	48

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings